<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03259191</url>
  </required_header>
  <id_info>
    <org_study_id>GI of Zhongda</org_study_id>
    <nct_id>NCT03259191</nct_id>
  </id_info>
  <brief_title>Anti-reflux Mucosectomy (ARMS) is a Useful Therapy for Refractory Gastroesophageal Reflux Disease (RGERD)</brief_title>
  <official_title>Department of Gastroenterology, Zhongda Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ruihua Shi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zhongda Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux
      disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 20, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 20, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement of symptoms</measure>
    <time_frame>1 month, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months</time_frame>
    <description>Improvement of all the symptoms related with RGERD.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications of ARMS</measure>
    <time_frame>1 month, 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months</time_frame>
    <description>Complications of ARMS,such as esophageal stenosis and dysphagia.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Refractory Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>completely circumferential ARMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>semi-circumferential ARMS</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>anti-reflux mucosectomy</intervention_name>
    <description>Anti-reflux mucosectomy (ARMS) may be a new therapy for refractory gastroesophageal reflux disease (RGERD). The aim of the present study is to explore the safety and efficacy of ARMS.</description>
    <arm_group_label>completely circumferential ARMS</arm_group_label>
    <arm_group_label>semi-circumferential ARMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Full sufficiency in literacy

          2. Be off proton pump inhibitor, antacids and prokinetics â‰¥ 2 weeks

          3. Refractory gastroesophageal reflux disease

        Exclusion Criteria:

          1. Severe heart, lung, and cerebrovascular disease

          2. Severe hematopoietic system disease

          3. Abnormal blood coagulation function

          4. Oropharyngeal abnormalities

          5. Severe spine malformation

          6. In pregnancy and lactation at present, or plan to become pregnant within 2 years

          7. Severe inflammation or huge ulcers in stomach

          8. Mental and psychological disorde
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Huiping Wang</last_name>
    <role>Study Chair</role>
    <affiliation>Zhongda Hospital Southeast University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruihua Shi, MD,PhD</last_name>
    <phone>+8613951799326</phone>
    <email>ruihuashi@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiacheng Tan, MD,PhD</last_name>
    <phone>+8615105165989</phone>
    <email>cencen_njjs@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiacheng Tan</last_name>
      <phone>8615105165989</phone>
      <email>cencen_njjs@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 20, 2017</study_first_submitted>
  <study_first_submitted_qc>August 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 23, 2017</study_first_posted>
  <last_update_submitted>August 20, 2017</last_update_submitted>
  <last_update_submitted_qc>August 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Zhongda Hospital</investigator_affiliation>
    <investigator_full_name>Ruihua Shi</investigator_full_name>
    <investigator_title>MD, PhD, Postdoctoral Mentor, Chief Physician</investigator_title>
  </responsible_party>
  <keyword>Anti-reflux mucosectomy,refractory gastroesophageal reflux disease,safety,efficacy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

